Corine Gaillez

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Maria Antonietta D’Agostino, Richard J. Wakefield, Hilde Berner-Hammer et al. · Annals of the Rheumatic Diseases · 2016 · 99 citations · Full text

Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study

Maria Antonietta D’Agostino, Maarten Boers, Richard J. Wakefield et al. · RMD Open · 2016 · 78 citations · Full text

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial

Philip G. Conaghan, Patrick Durez, Rieke Alten et al. · Annals of the Rheumatic Diseases · 2012 · 62 citations · Full text

Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III Study

Laura C. Coates, Philip J. Mease, Laure Gossec et al. · Arthritis Care & Research · 2018 · 45 citations

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)

Josef S Smolen, J. Wollenhaupt, Juan J. Gómez‐Reino et al. · Arthritis Research & Therapy · 2015 · 39 citations · Full text